Lonza Introduces The FlashGel™ Power Supply

Source : Lonza

Basel, Switzerland / Cologne, Germany, 26 November 2012 – Lonza introduces the FlashGel™ Power Supply, a high voltage electrophoretic power supply designed to complement the FlashGel™ System. When paired with the FlashGel™ Dock and FlashGel™ Camera, the FlashGel™ Power Supply provides a complete device system for separation of nucleic acids.

“We’re excited to offer this extension to our FlashGel™ System. We’ve accomplished our goal of designing a small, simple and easy to use device, capable of delivering 300 volts. With its built-in timer, you simply set it, push start and your FlashGel™ Power Supply runs for the desired time.” explains Denise Trevarrow, Product Manager at Lonza.

The FlashGel™ Power Supply is the newest addition to the FlashGel™ System. The FlashGel™ System uses precast gel cassettes in the FlashGel™ Dock, which is a combination gel runner and transilluminator. Cassette formats for DNA, RNA and recovery applications are available. The FlashGel™ System features 5 minute separation and recovery, real time separation and documentation, and outstanding sensitivity and resolution.

For more information visit: http://www.flashgel.com/ To download a high resolution version of the FlashGel™ Power Supply image, please click here.

About Lonza Bioresearch

Lonza provides the BioResearch market with the tools life science researchers use to develop and test therapeutics, from basic research through to final product release. Lonza Bioscience products and services range from cell culture and discovery technologies for research, to quality control tests and software to ensure product quality. Lonza serves research customers worldwide in pharmaceutical, biopharmaceutical, biotechnology and personal care companies, as well as academic and government research institutions.

The company delivers physiologically relevant cell biology solutions, biomarker discovery services, technologies to understand compound action and complete solutions for rapid microbiology. Primary brands include BioWhittaker™, Clonetics™, FlashGel™, MetaPhor™, MycoAlert™, Nucleofection™, NuSieve™, PAGEr™, Poietics™, SeaKem® and StellARray®.

Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange and secondary listed on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza is not subject to the SGX-ST’s continuing listing requirements. Lonza is subject to the listing rules of the SIX Swiss Exchange, which do not have specific requirements equivalent to the listing rules of the SGX-ST in respect of interested person transactions, acquisition and realizations, and delisting. In 2011, the company had sales of CHF 2.692 billion. Further information can be found at www.lonza.com. Further Information: Lonza Cologne GmbH
Marketing Communications and Product PR
Corinna König-Wildförster
Phone +49 221 99199 464


Lonza Group Ltd
Media Relations
Melanie Disa
Phone +1 201 316 9413

Fax +1 201 696 3533

  • <<
  • >>

Articles List

  • Therapeutic Antibodies

    Therapeutic Antibodies

    In the pharmaceuticals industry, antibodies are big business. Pharmaceuticals companies are keen to build on that success, and their development pipelines are full of new antibodies. But many of these aren’t your garden-variety IgGs. Modern antibody therapeutics are more sophisticated than ever.
  • Stereomicroscopes: Seeing More in 3D than Ever Before

    Stereomicroscopes: Seeing More in 3D than Ever Before

    Depending on the magnification, stereoscopes can provide large fields of view or zoom in on details of interest. Unlike other microscopes, stereoscopes also have a large working distance to allow for experimental tasks. These qualities make stereoscopes ideal for applications that require manipulations and hand-eye coordination, such as dissection and microsurgery in biology.

Disqus Comments